Cardinal Health partnered with Abbott and Quidel to offer rapid OTC COVID-19 tests
On Aug. 10, 2021, Cardinal Health announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19…
CDC reported vaccination offers higher protection than previous COVID-19 infection
On Aug. 6, 2021, the Centers for Disease Control and Prevention (CDC) annouced in MMWR that a study…
FDA approved new treatment for Pompe Disease
On Aug. 6, 2021, the U.S. Food and Drug Administration approved Genzyme’s Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion…
NIH-funded study discovered gene involved in male infertility
On Aug. 5, 2021, an international team of researchers announced that a mutation in a single gene appeared…
Lenzilumab treatment may provide enhanced likelihood of survival without ventilation in hospitalized black and African-American COVID-19 patients
On Aug. 4, 2021, Humanigen announced analysis of results from its Phase 3 LIVE-AIR study of lenzilumab in…
Bio-Techne’s RNAscopeﾙ aids in tissue diagnosis of COVID-19 in cases with no previous SARS-CoV-2 testing
On Aug. 4, 2021, Bio-Techne announced that scientists at the U.S. Centers for Disease Control and Prevention (CDC)…
Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
On Aug. 3, 2021, Eli Lilly and Incyte announced results from an additional cohort of 101 adult patients…
Vanda closed enrollment in ODYSSEY study comparing tradipitant and placebo In COVID-19 pneumonia patients
On Aug. 3, 2021, Vanda Pharmaceuticals announced that enrollment had closed in the ODYSSEY study comparing tradipitant and…
FDA cleared Vaxart’s IND application for S-only oral tablet COVID-19 vaccine candidate
On Aug. 2, 2021, Vaxart announced that the U.S. Food and Drug Administration had cleared Vaxart’s Investigational New…
MPP, WHO, AFRIGEN, BIOVAC, SAMRC and Africa CDC announced LOI for tech transfer hub in South Africa
On Jul. 30, 2021, the Medicines Patent Pool and the World Health Organization, Afrigen Biologics, the Biologicals and…
NIH advanced ACTIV-5/BET-B trial evaluating lenzilumab from phase 2 study to phase 2/3 trail for treatment of COVID-19
On Jul. 30, 2021, Humanigen announced that the NIH had advanced the ACTIV-5/BET-B study to a Phase 2/3…
FDA expanded authorized use of REGEN-COVﾙ (casirivimab and imdevimab)
On Jul. 30, 2021, Regeneron announced that the FDA had updated the Emergency Use Authorization (EUA) for the…
Oxford vaccine reached one billion doses released
On Jul. 29, 2021, the University of Oxfordﾒs and AstraZeneca announced that one billion doses of the ChAdOx1…
National Science Foundation partnerships expand National AI Research Institutes to 40 states
On Jul. 29, 2021, the National Science Foundation announced the establishment of 11 new NSF National Artificial Intelligence…
Researchers identified a cellular defect common to familial and sporadic forms of ALS
On Jul. 28, 2021, the National Institutes of Health announced that by studying lab-grown neurons derived from skin…
COVID-19 vaccine delivered into nose of research animals reduced nasal virus shedding
On Jul. 27, 2021, the National Institutes of Health announced that the COVID-19 vaccine AZD1222, when delivered into…
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | FDA | Life Science History | Therapeutics | Vaccine
The COVID-19 Vaccine
Cast of Characters: Donald Trump, President | Mike Pence, Vice President | Anthony S. Fauci, MD, Director, National…
American Nurses Association supported mandated COVID-19 vaccinations for nurses and all health care professionals
On Jul. 26, 2021, the American Nurses Association (ANA), representing the interests of the nationﾒs 4.2 million registered…
COVAX and World Bank accelerated COVID-19 vaccine access for developing countries
On Jul. 26, 2021, COVAX and the World Bank accelerated COVID-19 vaccine supply for developing countries through a…
Phase I trial began of new vaccine against the Plague
On Jul. 26, 2021, researchers at the University of Oxford launched a Phase 1 trial to test a…
Trevena announced first patient enrolled in NIH-funded ACTIV-4 host tissue trial of TRV027 for COVID-19
On Jul. 26, 2021, Trevena announced that the first COVID-19 patient had been enrolled in the NIH-funded ACTIV-4…
American Medical Association announced support of COVID-19 vaccine mandates for health care workers
On Jul. 26, 2021, the American Medical Association (AMA) call for all health care and long-term care employers…
Relief announced that U.S. collaboration had reporteded successful commercial formulation for aviptadil
On Jul. 23, 2021, RELIEF THERAPEUTICS announced that the parent company of its collaboration partner, NRx Pharmaceuticals, reported…
Pfizer and BioNTech to supply U.S. Government with additional 200 million doses of COVID-19 vaccine
On Jul. 23, 2021, Pfizer and BioNTech announced that the U.S. government had purchased an additional 200 million…
Humanigenﾒs partner in South Korea received pproval to conduct phase 1 study of lenzilumab
On Jul. 21, 2021, Humanigen announced its development and commercialization partners for South Korea and the Philippines, Telcon…
Twist Bioscience began shipping synthetic RNA positive controls for Delta (B.1.617.2) SARS-CoV-2 variant
On Jul. 22, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…
Moderna announced agreement with Taiwan for 20 million doses of Moderna’s COVID-19 Vaccine and variant booster
On Jul. 22, 2021, Moderna announced a new supply agreement with Taiwan for 20 million doses of Moderna’s…
Sorrento announced dosing of COVID-19 patients in phase 2 clinical trial for COVIDROPS neutralizing antibody against SARS-CoV-2
On Jul. 21, 2021, Sorrento Therapeutics announced that COVID-19 patients had been dosed in its Phase 2 efficacy…
Pfizer and BioNTech announced collaboration with Biovac to manufacture and distribute COVID-19 vaccine doses in Africa
On Jul. 21, 2021, Pfizer and BioNTech announced the signing of a letter of intent with The Biovac…
Japan became first country to approve Ronapreve (casirivimab and imdevimab) for ttreatment of mild to moderate COVID-19
On Jul. 20, 2021, Roche announced that Japanﾒs Ministry of Health, Labour and Welfare (MHLW) had approved Ronapreveﾙ(casirivimab…